Tilray Inc. (NASDAQ: TLRY) shares were up since last night as they rose 25.67% to $53.30 in the premarket session. The stock listed gains of 274.45% over the last month, 339.77% over the past three months, and 431.37% over the last six months. The volatility of TLRY in the past week was 17.89%, while it was 15.78% in a month.
Most Recent Announcement by Tilray Inc. (NASDAQ: TLRY)
On February 09, 2021, in an agreement with Grow Pharma, Tilray Inc. (NASDAQ: TLRY) announced it is importing and distributing Tilray’s medical products into the United Kingdom. Through this agreement, Tilray is able to provide UK medical cannabis patients in need with locally maintained supplies.
Medical cannabis products from Tilray are expected to be available for patients in the UK by March 2021.
Access to Tilray products in the UK will be available to patients with a prescription from a private doctor or from the National Health Service (NHS).
Brendan Kennedy, the Chief Executive Officer of Tilray, explained, This partnership strengthens patients’ access to GMP-certified, high-quality medical cannabis in the UK and is an important step toward increasing access in Europe and around the world.
“We’re pleased to join forces with Tilray and provide patients in need with a secure, sustainable supply of high-quality medical cannabis products in the UK,” said Pierre van Weperen, CEO of Grow Pharma.
Mergers and Acquisitions often improve investors’ sentiment towards a stock as was the case here. It’s a significant step forward for Tilray Inc. (NASDAQ: TLRY) toward its global expansion, and this news caused the stock to skyrocket yesterday and today.